首页> 外文期刊>Experimental Brain Research >Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons.
【24h】

Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons.

机译:腺苷受体配体可防止小脑颗粒神经元的凋亡和坏死细胞组合死亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Agonists at A(1) receptors and antagonists at A(2A) receptors are known to be neuroprotective against excitotoxicity. We set out to clarify the mechanisms involved by studying interactions between adenosine receptor ligands and endogenous glutamate in cultures of rat cerebellar granule neurons (CGNs). Glutamate and the selective agonist N-methyl-D: -aspartate (NMDA), applied to CGNs at 9 div (days in vitro), both induced cell death in a concentration-dependent manner, which was attenuated by treatment with the NMDA receptor antagonists dizocilpine, D: -2-amino-5-phosphono-pentanoic acid (D: -AP5) or kynurenic acid (KYA), but not by the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Glutamate toxicity was reduced in the presence of all of the following: cyclosporin A (CsA), a blocker of the membrane permeability transition pore, the caspase-3 inhibitor, benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone (Z-DEVD-fmk), the poly (ADP-ribose) polymerase (PARP-1) inhibitor 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ), and nicotinamide. This is indicative of involvement of both apoptotic and necrotic processes. The A(1) receptor agonist, N (6)-cyclopentyladenosine (CPA), and the A(2A) receptor antagonist 4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5]triazo-5-yl-amino]ethyl)phe nol (ZM241385) afforded significant protection, while the A(1) receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and the A(2A) receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxyamidoadenosine (CGS21680) had no effect. These results confirm that glutamate-induced neurotoxicity in CGNs is mainly via the NMDA receptor, but show that a form of cell death which exhibits aspects of both apoptosis and necrosis is involved. The protective activity of A(1) receptor activation or A(2A) receptor blockade occurs against this mixed profile of cell death, and appears not to involve the selective inhibition of classical apoptotic or necrotic cascades.
机译:已知A(1)受体的激动剂和A(2A)受体的拮抗剂对兴奋性毒性具有神经保护作用。我们着手阐明研究大鼠小脑颗粒神经元(CGNs)培养物中腺苷受体配体与内源性谷氨酸盐之间相互作用的机制。谷氨酸和选择性激动剂N-甲基-D:-天冬氨酸(NMDA)在9 div(体外天数)应用于CGNs时,均以浓度依赖性方式诱导细胞死亡,并通过使用NMDA受体拮抗剂治疗而减弱地佐西平,D:-2-氨基-5-膦酰基戊酸(D:-AP5)或犬尿酸(KYA),但不是由非NMDA受体拮抗剂6-氰基-7-硝基喹喔啉-2,3-二酮(CNQX)。在以下所有条件下降低谷氨酸的毒性:环孢菌素A(CsA),膜通透性过渡孔的阻滞剂,caspase-3抑制剂,苄氧羰基-Asp(OMe)-Glu(OMe)-Val-Asp( OMe)-氟甲基酮(Z-DEVD-fmk),聚(ADP-核糖)聚合酶(PARP-1)抑制剂3,4-二氢-5- [4-(1-哌啶基)丁氧基] -1(2H)-异喹啉酮(DPQ)和烟酰胺。这表明细胞凋亡和坏死过程均参与。 A(1)受体激动剂,N(6)-环戊基腺苷(CPA)和A(2A)受体拮抗剂4-(2- [7-氨基-2- [2-呋喃基] [1,2,4]三唑并[2,3-a] [1,3,5]三唑-5-基-氨基]乙基] nol(ZM241385)提供了重要的保护,而A(1)受体阻滞剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)和A(2A)受体激动剂2-对-(2-羧乙基)苯乙基氨基-5'-N-乙基羧酰胺基腺苷(CGS21680)没有作用。这些结果证实,谷氨酸诱导的CGNs神经毒性主要是通过NMDA受体引起的,但表明涉及细胞凋亡的一种形式,表现出凋亡和坏死方面。 A(1)受体激活或A(2A)受体阻滞的保护活性针对这种混合的细胞死亡而发生,并且似乎不涉及经典凋亡或坏死级联的选择性抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号